0001437749-16-027083.txt : 20160308
0001437749-16-027083.hdr.sgml : 20160308
20160308170021
ACCESSION NUMBER: 0001437749-16-027083
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160304
FILED AS OF DATE: 20160308
DATE AS OF CHANGE: 20160308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oxford Immunotec Global PLC
CENTRAL INDEX KEY: 0001586049
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
BUSINESS PHONE: 44 01235 442780
MAIL ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Edwardson Peter
CENTRAL INDEX KEY: 0001592279
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36200
FILM NUMBER: 161492190
MAIL ADDRESS:
STREET 1: C/O OXFORD IMMUNOTEC GLOBAL PLC
STREET 2: 94C INNOVATION DRIVE
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
4
1
rdgdoc.xml
FORM 4
X0306
4
2016-03-04
0001586049
Oxford Immunotec Global PLC
OXFD
0001592279
Edwardson Peter
C/O OXFORD IMMUNOTEC GLOBAL PLC
94C INNOVATION DRIVE
ABINGDON, OXFORDSHIRE
X0
OX14 4RZ
UNITED KINGDOM
1
Chief Operations Officer
Ordinary Shares
2016-03-04
4
A
0
9469
0
A
53801
D
Share Option (Right to Buy)
10.21
2016-03-04
4
A
0
39454
0
A
2026-03-04
Ordinary Shares
39454
39454
D
Option granted under Issuer's 2013 Share Incentive Plan.
Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2017 through January 1, 2020.
/s/ Elizabeth M. Keiley, as Attorney-in-Fact
2016-03-08